Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Glycomine Inc.
Sponsor

Glycomine Inc.

United States 733 Industrial Road, 94070-3310, United States

About the sponsor

Glycomine Inc. focuses on PMM2-CDG, a rare inherited metabolic disorder affecting protein glycosylation and multiple organ systems.

  • PMM2-CDG
  • Inherited metabolic disease
  • Glycosylation defects

The sponsor’s clinical activity centers on this ultra-rare disease area, with research spanning pediatric, adolescent, and adult populations.

About Specializations

Glycomine Inc. runs clinical trials in conditions such as Metabolic disorder, Congenital disorder of glycosylation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Metabolic disorder

Recruiting
InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:M1P Dipotassium Salt
  • Sponsor:Glycomine Inc.

Congenital disorder of glycosylation

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:M1P Dipotassium Salt
  • Sponsor:Glycomine Inc.

Metabolic disorder

Not recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Alfa-D-Mannopyranosyl Phosphate Dipotassium
  • Sponsor:Glycomine Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.